These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17346254)

  • 1. Severe relapse of epilepsy after vigabatrin withdrawal: for how long should we treat symptomatic infantile spasms?
    Kröll-Seger J; Kaminska A; Moutard ML; de Saint-Martin A; Guët A; Dulac O; Chiron C
    Epilepsia; 2007 Mar; 48(3):612-3. PubMed ID: 17346254
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral MRI abnormalities associated with vigabatrin therapy.
    Pearl PL; Vezina LG; Saneto RP; McCarter R; Molloy-Wells E; Heffron A; Trzcinski S; McClintock WM; Conry JA; Elling NJ; Goodkin HP; de Menezes MS; Ferri R; Gilles E; Kadom N; Gaillard WD
    Epilepsia; 2009 Feb; 50(2):184-94. PubMed ID: 18783433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vigabatrin therapy in infantile spasms.
    Kankirawatana P; Raksadawan N; Balangkura K
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S778-83. PubMed ID: 12403260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin administration in patients with infantile spasms: the risks.
    Jaseja H
    Clin Neurol Neurosurg; 2010 Nov; 112(9):835. PubMed ID: 20934097
    [No Abstract]   [Full Text] [Related]  

  • 6. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.
    Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Lux AL; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Arch Dis Child; 2010 May; 95(5):382-6. PubMed ID: 20457702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin in the treatment of infantile spasms.
    Vles JS; van der Heyden AM; Ghijs A; Troost J
    Neuropediatrics; 1993 Aug; 24(4):230-1. PubMed ID: 8232783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of infantile spasms.
    Desguerre I; Nabbout R; Dulac O
    Arch Dis Child; 2008 Jun; 93(6):462-3. PubMed ID: 18192314
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy of infantile spasms: new opportunities and emerging challenges.
    Mikati MA; Cornett KM
    Epilepsy Behav; 2010 Apr; 17(4):571-3. PubMed ID: 20097137
    [No Abstract]   [Full Text] [Related]  

  • 10. Current role of vigabatrin in infantile spasms.
    Parisi P; Bombardieri R; Curatolo P
    Eur J Paediatr Neurol; 2007 Nov; 11(6):331-6. PubMed ID: 17625936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms.
    Dracopoulos A; Widjaja E; Raybaud C; Westall CA; Snead OC
    Epilepsia; 2010 Jul; 51(7):1297-304. PubMed ID: 20384718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin therapy in infantile spasms: solving one problem and inducing another?
    Wohlrab G; Leiba H; Kästle R; Ramelli G; Schmitt-Mechelke T; Schmitt B; Landau K
    Epilepsia; 2009 Aug; 50(8):2006-8. PubMed ID: 19682036
    [No Abstract]   [Full Text] [Related]  

  • 13. Vigabatrin: new indication. An advance in infantile spasms.
    Prescrire Int; 1998 Apr; 7(34):43-4. PubMed ID: 10183381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin for the treatment of infantile spasms: final report of a randomized trial.
    Elterman RD; Shields WD; Bittman RM; Torri SA; Sagar SM; Collins SD
    J Child Neurol; 2010 Nov; 25(11):1340-7. PubMed ID: 20404353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin as a first-choice drug in the treatment of West syndrome.
    Fejerman N; Cersósimo R; Caraballo R; Grippo J; Corral S; Martino RH; Martino G; Aldao M; Caccia P; Retamero M; Macat MC; Di Blasi MA; Adi J
    J Child Neurol; 2000 Mar; 15(3):161-5. PubMed ID: 10757471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin monotherapy in resistant neonatal seizures.
    Baxter PS; Gardner-Medwin D; Barwick DD; Ince P; Livingston J; Murdoch-Eaton D
    Seizure; 1995 Mar; 4(1):57-9. PubMed ID: 7788110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
    Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin in infantile spasms: preliminary result.
    Visudtibhan A; Chiemchanya S; Visudhiphan P; Phusirimongkol S
    J Med Assoc Thai; 1999 Oct; 82(10):1000-5. PubMed ID: 10561962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of vigabatrin in infantile spasms in Asian children.
    Tay SK; Ong HT; Low PS
    Ann Acad Med Singap; 2001 Jan; 30(1):26-31. PubMed ID: 11242620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.